8-KOther Events

Merck & Co., Inc. 8-K Report (Jul 21, 2004)

Filed July 21, 2004For Securities:MRK

Summary

This 8-K filing by Schering-Plough Corporation (MRK) on July 21, 2004, primarily serves to attach their press release and supplemental financial data detailing their second-quarter 2004 financial results. While the filing itself does not contain a direct analysis of the numbers, it points investors to these attached documents for detailed financial performance information for the period ending June 30, 2004. The filing also includes extensive cautionary statements regarding forward-looking information, highlighting numerous risks and uncertainties that could materially impact the company's future financial and operational results. These risks encompass competitive pressures, regulatory changes, patent expirations, product development challenges, and economic factors, among others. Investors should consult the referenced press release and supplemental data for the specific financial outcomes of the quarter and review the cautionary statements carefully to understand the potential volatility and risks associated with the company's future prospects.

Key Highlights

  • 1Schering-Plough Corporation (MRK) filed an 8-K on July 21, 2004, to report its second-quarter 2004 financial results.
  • 2The filing includes Exhibit 99.1: the press release 'Schering-Plough Reports Financial Results for 2004 Second Quarter'.
  • 3Exhibit 99.2: Supplemental Financial Data related to the second-quarter results is also attached.
  • 4The report contains comprehensive 'Disclosure Notice for Forward Looking Statements' and 'Cautionary Factors That May Affect Future Results'.
  • 5These cautionary statements outline a broad range of risks including competitive pressures, patent issues, regulatory challenges, and product development uncertainties.
  • 6Investors are advised to review the attached press release and supplemental data for specific financial performance details.
  • 7The filing emphasizes that actual results could differ materially from forward-looking statements due to various risk factors.

Frequently Asked Questions

The primary purpose of this 8-K filing by Schering-Plough on July 21, 2004, is to formally report and attach their press release and supplemental financial data concerning their financial results for the second quarter of 2004.

The actual financial results for the second quarter of 2004 are detailed in the press release titled 'Schering-Plough Reports Financial Results for 2004 Second Quarter' (Exhibit 99.1) and the accompanying Supplemental Financial Data (Exhibit 99.2), which are attached to this 8-K filing.

The filing extensively discusses potential risks and uncertainties that could affect future results. These include, but are not limited to, intense competition, patent expirations and disputes, pricing pressures from healthcare organizations, regulatory hurdles with the FDA and other international bodies, product development failures, safety concerns with existing products, and general economic factors. Investors should carefully read the 'Cautionary Factors' section for a comprehensive overview.

This 8-K filing itself primarily serves as a notification and attachment mechanism for the company's second-quarter earnings release and related data. While it includes extensive cautionary language about future outlooks, it does not contain a detailed analytical commentary on the reported financial performance; that analysis is expected to be found within the attached press release and supplemental data.